Search | eNauka

Research outputs

The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C [2013]

Lazarević, Ivana ; Djordjevic, Jelena; Ćupić, Maja ; Karalić, Danijela ; Delić, Dragan ; Svirtlih, Neda; Simonović-Babić, Jasmina ; Svorcan, Petar ; Milić, Nataša ; Jovanović, Tanja

Influenza surveillance in Serbia: use of rapid cell culture assay [2006]

Nedeljković, Jasminka M.; Mitrović, J.; Jovanović, Tanja

Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques [2003]

Simpson, JL; Morić, Ivana ; Wark, PAB; Johnston, SL; Gibson, PG

Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells [1999]

Nedeljković, Jasminka; Jovanović, T.; Mlađenović, S.; Hedman, K.; Peitsaro, N.; Oker-Blom, C.

Measles elimination in the World Health Organization European Region in light of recent outbreaks: Spotlight on the Balkans [2015]

Huebschen, Judith M.; Salimović-Besić, I.; Dedeić-Ljubović, A.; Rakić-Adrović, Slavica; Sausy, A.; Muller, Claude P.

Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study [2020]

Popescu, Corneliu Petru; ...; Dragovac, Gorana S ; ...; Djekic-Malbasa, Jelena N ; Strbac, Mirjana; ...; (broj, koautora 27)

The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation [2010]

Jevtović, Đorđe ; Salemović, D.; Ranin, Jovan ; Dulović, O.; Ilić, Dragan ; Brmbolić, Branko

Maturation of IgG avidity to individual rubella virus structural proteins [2001]

Nedeljković, Jasminka; Jovanović, T.; Oker-Blom, C.

The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia [2013]

Milošević, Ivana ; Delić, Dragan ; Lazarević, Ivana ; Pavlovic, Ivana Pesic; Korać, Miloš ; Bojović, Ksenija ; Jevtović, Đorđe

A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B - a phase IIa clinical trial [2006]

Schneider, J.; Halota, W.; Delić, Dragan; Nešić, Zorica ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, J.; Jablkowski, M.; Cianciara, J.; Mach, T.;

Modrzewska, R.; Fabri, Miloš; Tomić, Dragan; Horban, A.; Krycka, W.; Cripps, M.;